ArticleDrug delivery and translational research2026
Endothelial progenitor cells-derived exosomes reduce ferroptosis and promote neovascularization after intracranial atherosclerosis in association with the NCOA4/FTH1 cascade modulation.
Article in Drug delivery and translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Intracranial atherosclerosis (ICAS) is a leading cause of ischemic stroke. This study explored the mechanism of endothelial progenitor cells-derived exosomes (EPCs-exos) in ICAS. Rat EPCs were isolated, EPCs-exos were extracted and identified. A rat model of ICAS was established, and EPCs and EPCs-exos or lentiviral si-NCOA4 were injected into rats to observe the histopathological changes in cerebral microvessels, ferroptosis, angiogenesis, inflammatory indexes, and the NCOA4/FTH1 pathway. Hematoxylin and eosin staining was performed to observe the histopathology of cerebral microvascular tissue. EPCs were successfully isolated from rats and EPCs-exos were identified. EPC treatment inhibited the NCOA4/FTH1 pathway, hindered inflammatory responses and ferroptosis in ICAS rats, promoted neovascularization, and improved histopathology. EPCs-exos similarly reduced inflammatory responses and ferroptosis and promoted neovascularization in ICAS rats. In conclusion, EPCs‑exos reduce ferroptosis, attenuate inflammatory responses, and enhance cerebral neovascularization in ICAS rats in association with the NCOA4/FTH1 pathway modulation.
Indexed as
Identifiers
42603839What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.